| 1 |
31744669 | Validation of a sensitive UHPLC-MS/MS method for cytochrome P450 probe substrates caffeine, tolbutamide, dextromethorphan, and alprazolam in human serum reveals drug contamination of serum used for research. | 2020 Feb 5 |
1 |
| 2 |
32050158 | An improved cytochrome P450 phenotyping cocktail with a simplified and highly sensitive UHPLC-MS/MS assay in human plasma. | 2020 Mar 1 |
1 |
| 3 |
32279279 | The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions. | 2020 Dec |
1 |
| 4 |
31123759 | Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity. | 2019 Sep |
3 |
| 5 |
29063606 | Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs. | 2018 Feb |
1 |
| 6 |
27127017 | The CYTONOX trial. | 2016 May |
1 |
| 7 |
23682612 | The effect of organic solvents on enzyme kinetic parameters of human CYP3A4 and CYP1A2 in vitro. | 2013 Oct |
1 |
| 8 |
22725721 | A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4. | 2012 Nov |
1 |
| 9 |
20716633 | Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. | 2010 Sep |
1 |
| 10 |
20924570 | Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women. | 2010 Dec |
1 |
| 11 |
20002088 | Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. | 2009 Dec |
1 |
| 12 |
15997229 | Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula. | 2005 Sep |
1 |
| 13 |
12376329 | Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. | 2002 Nov |
1 |
| 14 |
10634135 | Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine. | 1999 Dec |
3 |
| 15 |
9868741 | Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro. | 1998 Dec |
2 |
| 16 |
10076532 | Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats. | 1998 May 1 |
1 |
| 17 |
9390105 | Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants. | 1997 Nov |
1 |
| 18 |
8930576 | Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs. | 1996 Oct |
1 |